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Abstract
Background: Aryl Hydrocarbon Receptor (AhR) is a ligand-activated transcription factor with multiple functions
operating in a variety of organs, including the brain. Recent studies have revealed that AhR played a functional role
in traumatic injuries. This paper aims to study the expression of AhR during the early phase following a traumatic
brain injury (TBI) in rat brains by immunohistochemistry.
Methods: Weight-drop induced TBI was performed in rats. The expression of AhR in brain of TBI rats were
examined by immunohistochemistry.
Results: Neuron expression of AhR in the rat brains of experiment group had been upregulated since day 3 in
lesional hemisphere compared to that of the control group and mainly located in the cytoplasm, indicating an
inactivated state. Interestingly, the accumulation of AhR+ non-neuron cells became significant as early as 18 h
after injury, which had kept increasing until 24 h post injury and then decreased slowly. For AhR+ non-neuron cells,
the AhR mainly located in cell nucleus, indicating a reactive status. Furthermore, double staining showed that
most AhR+ non-neuron cells co-localized with W3/13, a marker for T lymphocytes, but not with ED-1 (for activated
microglia/macrophages) or GFAP (for activated astrocytes), suggesting that most AhR+ non-neuron cells were
T lymphocytes.
Conclusion: This is the first study concerning AhR expression in brains following TBI, and our data demonstrated
that AhR was upregulated and activated in T lymphocytes following TBI. More research is needed to make a more
conclusive conclusion.
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Background
Traumatic brain injury (TBI) is a major public health
threat in the society. While the contact and initial force
cause multifocal lesions, the secondary injury can be
more dreadful and diffuse. Delayed neuronal death in
secondary injury can be due to several cellular and
subcellular cascades such as release of excitatory amino
acid (EAA), influx of Ca++, and mechanical distortion of
the cell membrane [1].
Immune responses in the CNS have recently drawn
lots of attention, despite its long-lasting perception as a
site of immune privilege [2]. The infiltration of immune
cells following TBI has been well documented for some
cell types, including neutrophils, microglia/macrophages
and T lymphocytes [3]. Activated neutrophils upregulate
adhesion molecules to enhance their association and
migration into tissues and produce reactive intermedi-
ates, cytokines and chemokines, etc. Activated micro-
glia/macrophages show high heterogeneity, and the
activation may be beneficial, deleterious, or neutral [2].
Moreover, functions of T lymphocytes are more compli-
cated. Both CD4+ and CD8+ T cells that enter the brain
[4] and different subsets of T cells are involved in contra-
dictory activities like a double-edged sword [5]. These
immune cells orchestrate and lead to neuronal degener-
ation or regeneration/repair depending on the context [2].
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However, details on the changes and exact roles of
immune cells following TBI remain scarce.
Aryl Hydrocarbon Receptor (AhR) is a ligand-activated
transcription factor of the basic helix-loop-helix/per-ARNT-
Sim (bHLH/PAS) superfamily [6]. It can be activated by a
variety of exogenous and endogenous compounds [7]. Upon
ligand binding, AhR translocates into the nucleus to form
an active heterodimeric complex [8] and triggers rapid tran-
scriptional activations [9] in a variety of organs and cell sys-
tems. In addition to the classical knowledge of responding
to environmental toxicants via exogenous ligands, recent
studies pointed out that the physiological functions of AhR
included cell differentiation, apoptosis [10, 11], immune re-
sponse, [12] and injury repairing [13, 14].
AhR was identified in the brain [15], regulating neuronal
cell cycle control and apoptosis [16]. Moreover, AhR has
been identified in T lymphocytes and macrophages as a
regulator of cytokine production [17]. Recent studies also
revealed that AhR is involved in controlling helper T cell
differentiation [18, 19]. However, the expression of AhR fol-
lowing TBI remains unknown. Therefore, this experiment
was performed to study the spatiotemporal expression of
AhR in brains of weight-drop induced TBI rats.
Methods
TBI brain tissue library
The brain libraries of the control group and the experi-
ment group of rats used in this study have been described
previously [20]. In brief, weight-drop induced TBI was
performed in Lewis rats. This study was approved by the
Ethics Committee of Tuebingen University (No. HF 2/06).
Immunohistochemistry
A previous reported protocol for immunohistochemistry
was applied to detect the expression of different proteins
using following primary antibodies: anti-AhR (1:100; Life-
span Bioscience, Seattle, USA), anti-ED-1 (1:100; Serotec,
Oxford, Great Britain) for macrophages, anti-W3/13 (1:100;
Serotec, Oxford, Great Britain) for T lymphocytes and anti-
glial fibrillary acidic protein for astrocytes (GFAP; 1:500;
Chemicon International, Temecula, CA, USA) [20, 21].
Data acquisition and statistical analysis
After immunostaining, brain sections were examined by
light microscopy. For single AhR staining, the numbers
of AhR+ cells were counted in 8 non-overlapping high-
power fields (HPFs, x400 magnification) for each section.
Fig. 1 Immunohistochemical labeling of AhR in neurons of normal brains (b, d, e, and f) and brains 3 days post-TBI. a The specificity of AhR
antibody was demonstrated by staining without the primary antibody and no IR was seen. b, c Examples of coronal sections of the cortex
from normal brains (b) and brains 3 days after TBI (c). AhR expression (blue dots) was observed in the neurons of brain cortex in normal
brains (b) and elevated three days post injury (c). d–i Examples of coronal sections of the AhR expression in hippocampus from normal
brains (d–f) and brains 3 days after TBI (g–i). AhR expression was observed in neurons of pyramid cell layer of CA fields (e and h) and
granular layer of dentate gyrus (f and i) in normal brains (d–f) and elevated in brains 3 days after TBI (g–i). The boxed areas indicate regions
further observed under high-power magnification. The lower boxed areas represent the area of dentate gyrus and the upper boxed areas
hippocampal CA fields
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Results were presented as arithmetic means of AhR+
cells per HPF and standard errors of means (SEM). Stat-
istical analysis was performed by one-way ANOVA
followed by Dunnett’s multiple comparison tests (Graph
Pad Prism 4.0 software). The significance levels were set
at p < 0.05.
Results
In this study, open skull weight drop injury generates a repro-
ducible local lesion in the ipsilateral cortex. The development
of the lesion was first analyzed by Hematoxylin and Eosin
(HE) Staining and has been described previously by Zhang
[20]. In brief, significant leukocyte infiltration and hemorrhage
can be observed at the first day after injury. At day 4 post
injury, a lesioned cavity together with its surrounding perile-
sional tissue loss formed under the impact areas.
The expression of AhR in TBI and non-TBI brains was
analyzed by immunohistochemistry. In our applied weight-
drop model, cortex is the primary injury site. Moreover,
the traumatic impact may influence areas like the hippo-
campus, resulting in complex cognitive problems. There-
fore, the expression of AhR in cortex and hippocampus
was mainly investigated. In in the cortex of normal rat
brains, weak AhR immunoreactivity (IR) was observed,
which mainly localized to neuron cells (Fig. 1a, b). Simi-
larlly, weak IR of AhR was detected in hippocampus of
normal rats, which was observed in the pyramid cell layer
of CA fields (Fig. 1c, d) and granular layer of dentate gyrus
(Fig. 1e).
After TBI, no visible change of AhR IR was detected in
the contralateral hemisphere (Data not shown). In the in-
jured (ipsilateral) sides, AhR expression in neuron cells in
the cortex outside of lesion and hippocampus was upregu-
lated since day 3. As shown in Fig. 1c, g, h and i, more
AhR+ cells were observed and the IR of AhR became
stronger as well compared to normal control at day 3 post
injury. Interestingly, while an upregulation of AhR was ob-
served following TBI, IR of AhR in neuron cells in the cor-
tex and hippocampus was mainly localized to cytoplasm
but not nucleus, indicating an inactivated state.
However, the accumulation of non-neuron AhR+ cells
was observed in the lesion areas. We then quantified the
non-neuron AhR+ cells in lesional areas. After TBI, a slight
increase of AhR+ non-neuron cells was observed to be con-
fined to the lesion as early as 18 h post-injury (p.i.) (Fig. 2;
6.3 ± 1.5 per HPF, p > 0.05 compared to normal control).
The maximal accumulation of AhR+ non-neuron cells in
the lesional region was observed 24 h p.i. (36.0 ± 7.6 per
HPF, P < 0.001; Fig. 2 and Fig. 3b). Thereafter the ac-
cumulation of AhR+ non-neuron cells decreased with
Fig. 2 Time course of lesional AhR+ non-neuron cell accumulation
in TBI. The numbers of parenchymal AhR+ non-neuron cells of every
rat brain coronal section were counted in 8 HPFs. In each field, only
positive cells with the nucleus at the focal plane were counted. Results
were presented as arithmetic means of positive cells per HPF and
standard errors of means (SEM). Statistical analysis was performed by
one-way ANOVA followed by Dunnett’s Multiple Comparison test.
*: p < 0.05 compared to normal control
Fig. 3 Accumulation of AhR+ non-neuronal cells in traumatic
brains. In 12 h brains, AhR+ non-neuronal cells were rarely
seen (a). Accumulation of AhR+ non-neuronal cells in the
lesioned regions at day 1 (b), 2 (c) and 4 (d), respectively,
after TBI. e Micrographs show that most AhR+ non-neuronal
cells exhibited lymphocyte morphology with small cell body and
cytoplasm (blue and brown dots). f Occasionally, the localization of
AhR+ lymphocyte-like cells in the peri-vascular spaces corresponding
to peri-vascular spaces was observed, indicating the blood origin.
Furthermore, in AHR+ non-neuron cells, AhR was mainly localized to
nucleus, suggesting an activated status (e and f)
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time but still remained significantly higher than normal
control (48 h: 27.2 ± 5.4 per HPF, p < 0.05; 96 h: 15.6 ± 5.4
per HPF, p < 0.05; Fig. 2 and Fig. 3c, d).
At the lesioned site, most of the AhR+ cells exhibited
lymphocyte morphology with small cell body and cyto-
plasm (Fig. 3e). Occasionally, the localization of AhR+
lymphocyte-like cells at the peri-vascular spaces corre-
sponding to peri-vascular spaces was observed, indicat-
ing the blood origin (Fig. 3f ). More interestingly, in
AhR+ non-neuron cells, AhR mainly localized in
nucleus, suggesting an activated status (Fig. 3e, f ).
To further identify the cellular sources of these non-
neuron AhR+ cells in the lesions, we performed double-
staining experiments with W3/13 antibody (recognized T
lymphocytes), ED-1 antibody (recognized activated micro-
glia/macrophages) and GFAP antibody (recognized astro-
cytes). As shown in Fig. 4a, b, most non-neuron AhR + cells
were co-labeled with W3/13 (more than 90 %). ED-1+
microglia/macrophages and GFAP+ astrocytes very rarely
co-expressed AhR near the lesional areas following TBI
(Fig. 4c, d). Therefore T cells were the major cellular sources
of non neuronal AhR in the lesion areas following TBI.
Discussion
In this study, the expression of AhR in neurons of normal
rat brain was mainly detected in the cortex and hippocam-
pus in a low or moderate level, and occasionally found in
the pyramid cell layer of CA fields, which was similar to
previous report [15, 22]. In neurons, the expression of
AhR increased following TBI but was mainly localized in
the cytoplasm, indicating an inactivated state. However,
due to the relative insensitivity of our applied method, a
small amount of AhR may still exist in nucleus. Under
pathological conditions, the over-expression of AhR was
reported to induce neural differentiation [10] and AhR
was also involved in controlling neuron cell cycle and
apoptosis [11, 19].
The accumulation of AhR+ lymphocytes in lesional
areas following TBI was observed in our study. Normally,
T cells cannot enter the CNS. However, under patho-
logical conditions, such as activated by CNS-derived auto-
antigen and increased blood-brain barrier permeability, T
cells can infiltrate into CNS parenchyma and exert multi-
functions [23]. Clausen et al. reported that T lymphocytes
(both CD4+and CD8+ cells) were detected in the lesional
cortex at 12 h after TBI [3]. The reported infiltration,
which is similar to our observation, peaked at 24 h and
then slightly decreased.
Functions of T cells in brain injury are complicated and
conflicting observations have been reported by different
groups. Autoreactive Th1 cells by vaccination were re-
ported to improve functional recovery after closed head
injury [24]. Moreover, passive transferred autoreactive Th2
cells also accelerate recovery in spinal cord contusion [25].
Fig. 4 AhR double labeling in brain sections from day 1 after TBI. a Most AhR+ non-neuronal cells (brown) co-expressed W3/13 (blue). The boxed
areas indicate the regions that were further observed under high-power magnification shown in (b). c and d: However, most AhR+ non-neuronal
cells (blue) did not co-localize with ED1+ microglia (brown, c) or GFAP+ astrocytes (brown, d). Scale bar = 100 μm for (a, c) and d; 50 μm for (b)
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However, immediate post-lesional transfer of MBP-specific
T cells exacerbated lesion pathology in spinal cord contusion
[26]. Furthermore, depletion of regulatory T cells (Treg) by
CD25 antibody, reported by Liesz et al., profoundly in-
creased delayed brain damage and deteriorated functional
outcome in acute experimental stroke [27]. CD8+ T cells
were less studied in injury models, but they are proved to in-
filtrate the lesion after TBI and may also play a part in the
pathological process following TBI [3].
Currently, AhR can be detected in naïve T cells [28] and
its expression was reported in the Th17 and Treg subsets
[29] but not in Th1 or Th2 subsets [28]. Negishi et al.
reported a modulation of the naïve Th cell differentiation
into Th1/Th2 cells toward Th1 dominance under the
activation of AhR treated by representative AhR ligands in
vitro [28]. Moreover, 2,3,7,8-tetrachlorodibenzo-p-dioxin
(TCDD), the exogenous AhR ligand, promoted Treg
differentiation [18], while tryptophan photoproducts
6-formylindolo-[3,2-b]-carbazole (FICZ) would pro-
mote Th17 cell differentiation [18, 19]. AhR can also
be expressed in CD8+ T cells and promote CD8+
Treg cell differentiation under TCDD treatment [30].
In our investigation, accumulation of AhR+ T lymphocytes
was observed following TBI. Though the exact function of
AhR in TBI still remains unclear, AhR might modulate the
differentiation of T lymphocytes to influence the balance
of immune response and contribute to the outcome
of TBI [28, 29].
Conclusions
Taken together, we have shown an early accumulation of
activated AhR+ T cells in TBI. AhR expression might
play a role in the degeneration/regeneration processes
following TBI by modulating the differentiation of T
lymphocytes. Our results warrant future studies of the
AhR function in brain trauma.
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